Uplizna®

Uplizna® (inebilizumab-cdon) is a prescription medicine used to treat neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

MANUFACTURER:

Horizon Therapeutics

CLASS:
Monoclonal Antibody
WHAT IT TREATS:

Neuromyelitis optica spectrum disorder

PRESCRIBED BY:

Various

HOW ADMINISTERED:
Infusion
FREQUENCY:

2 treatments, 2 weeks apart, then 1 every 6 months

Length of infusion:
90 min